EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSFCAG00000036856
Gene Symbol: PTGER4
5 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSFCAG00000004947
Gene Symbol: PTGFR
5 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSFCAG00000027533
Gene Symbol: PTGIR
5 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSFCAG00000011194
Gene Symbol: PTGS1
5 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSFCAG00000023081
Gene Symbol: PTGS2
5 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSFCAG00000011381
Gene Symbol: PSMA1
5 Cross references
232 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSFCAG00000023349
Gene Symbol: PSMA2
5 Cross references
231 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSFCAG00000025134
Gene Symbol: PSMA3
5 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSFCAG00000039013
Gene Symbol: PSMA4
5 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSFCAG00000032218
Gene Symbol: PSMA5
5 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSFCAG00000026276
Gene Symbol: PSMA6
5 Cross references
274 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSFCAG00000003249
Gene Symbol: PSMA7
5 Cross references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).